NJ SCR107 | 2020-2021 | Regular Session

Note: Carry Foward to future SCR54
Note: Carry Over of previous SCR52

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 16 2020 - 25% progression, died in committee
Action: 2020-03-16 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Pending: Senate Health, Human Services and Senior Citizens Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Urges U.S. President, Congress, and Department of Health and Human Services to ease patient limits applicable to private physicians prescribing buprenorphine as part of medication-assisted treatment for substance use disorders.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Urges U.S. President, Congress, and Department of Health and Human Services to ease patient limits applicable to private physicians prescribing buprenorphine as part of medication-assisted treatment for substance use disorders.

Sponsors


History

DateChamberAction
2020-03-16SenateIntroduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Same As/Similar To

SCR107 (Carry Over) 2020-03-16 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
SCR52 (Carry Over) 2018-01-16 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Subjects


New Jersey State Sources


Bill Comments

feedback